Inhibitors of stone formation

Area of Science:

• Biochemistry
• Nephrology
• Urology

Background:

• Urine contains crystal inhibitors that protect the kidneys from pathological calcification.
• These inhibitors prevent kidney stone formation, particularly for calcium oxalate stones.
• Macromolecules like glycoproteins and glycosaminoglycans are key inhibitors.

Purpose of the Study:

• To review the known inhibitors of kidney stone formation in urine.
• To discuss the properties and mechanisms of these inhibitory molecules.
• To explore the potential role of inhibitor dysfunction in kidney stone disease.

Main Methods:

• Literature review of studies on urinary crystal inhibitors.
• Analysis of the chemical and structural properties of identified inhibitors.
• Examination of the association between inhibitor abnormalities and kidney stone formation.

Main Results:

• Key urinary inhibitors include nephrocalcin, Tamm-Horsfall protein, uropontin, and bikunin.
• These anionic macromolecules often have post-translational modifications (phosphorylation, glycosylation).
• Inhibitors exert effects by binding to crystal surfaces, primarily calcium oxalate.

Conclusions:

• Urinary inhibitors play a crucial role in preventing kidney stone formation.
• Abnormalities in inhibitor structure or function are found in some stone formers.
• Further research is needed to determine the prevalence of inhibitor dysfunction in kidney stone disease.